IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 93 filers reported holding IDENIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $880,000 | +201.4% | 36,496 | -24.7% | 0.00% | – |
Q1 2014 | $292,000 | +0.7% | 48,496 | 0.0% | 0.00% | – |
Q4 2013 | $290,000 | +18.9% | 48,496 | +3.4% | 0.00% | – |
Q3 2013 | $244,000 | +44.4% | 46,896 | 0.0% | 0.00% | – |
Q2 2013 | $169,000 | – | 46,896 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 29,665,693 | $153,965,000 | 4.40% |
Bain Capital Public Equity Management, LLC | 12,664,950 | $65,731,000 | 1.65% |
BRIDGER MANAGEMENT, LLC | 4,360,628 | $22,632,000 | 1.62% |
12 West Capital Management LP | 1,782,100 | $9,249,000 | 1.32% |
GENERAL AMERICAN INVESTORS CO INC | 858,979 | $4,458,000 | 0.39% |
BB BIOTECH AG | 1,250,000 | $6,488,000 | 0.35% |
Aris Wealth Services, Inc. | 30,000 | $156,000 | 0.28% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 800,400 | $4,154,000 | 0.16% |
Visium Asset Management, LP | 1,307,132 | $6,810,000 | 0.15% |
Old West Investment Management, LLC | 59,038 | $306,000 | 0.15% |